35
Participants
Start Date
February 28, 2010
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Selective cytopheretic device (SCD)
The selective cytopheretic device (SCD) is comprised of tubing, connectors and a hemofilter cartridge. The device is connected in series to a commercially available Continuous Renal Replacement Therapy (CRRT) device. Blood from the CRRT circuit is diverted after the CRRT hemofilter through to the extra capillary space (ECS) of the SCD. Blood circulates through this space and is returned to the patient via the venous return line of the CRRT circuit. Regional citrate anticoagulation is used for the entire CRRT and SCD blood circuits.
George Washington University, Washington D.C.
University of Alabama Birmingham, Birmingham
Memorial Hospital, Chattanooga
Mayo Clinic, Rochester
University of Texas, Houston
Denver Nephrology, Denver
University of California San Diego, San Diego
Lead Sponsor
Collaborators (2)
Baim Institute for Clinical Research
OTHER
Medtox
INDUSTRY
SeaStar Medical
INDUSTRY